China Pharmaceuticals and Healthcare Report Q2 2013

Business Monitor International Market Research Reports Market Reports Online XML Feed

China Pharmaceuticals and Healthcare Report Q2 2013 Mar 13th 2013, 00:00 BMI View: In general, China remains the key emerging market for multinational pharmaceutical firms,given their strong double-digit sales growth. In particular, Q412 was a milestone for some multinationalfirms in China, such as Merck & Co and Novartis. We highlight that companies both domestic and foreignwill continue to benefit from the country''s commitment to healthcare. However, a downside risk to thiswould be the government''s continued calls for more greater affordability, which results in pricingpressures.Headline Expenditure Projections? Pharmaceuticals: CNY517.9bn (US82.1bn) in 2012to CNY608.6bn (US$97.1bn) in 2012; +17.5% inlocal currency and +18.2%...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions